XingImaging is a CRO service provider of nuclear drug transformation and clinical trial imaging.
XingImaging has raised $3.8M in total funding. The most recent round was Grant. The last funding was announced in September 2025.
XingImaging's investors include Michael J. Fox Foundation.
XingImaging is headquartered in Madison, United States.
XingImaging is a CRO service provider of nuclear drug transformation and clinical trial imaging.
XingImaging is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"XingImaging — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/xingimaging. Accessed August 14, 2026.
VCBacked. (2025). XingImaging — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/xingimaging
{{cite web |title=XingImaging — Funding & Investors |url=https://www.vcbacked.co/company/xingimaging |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated